Monocyte chemoattractant protein-1-2518 A/G single nucleotide polymorphism might be associated with renal disease and thrombocytopenia of SLE

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Jagodziński, Pawe P ^a   Piotrowski, Piotr ^a,b   Lianeri, Margarita ^a   Gasik, Robert ^a,c   Roszak, Andrzej ^a,d   Olesińska, Marzena ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c INSTITUTE OF RHEUMATOLOGY   (Poland)

^d GREATER POLAND CANCER CENTRE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; CCL2 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; ALLELE; BLOOD; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; NONPARAMETRIC TEST;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHEMOKINE CCL2; FEMALE; HUMANS; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; STATISTICS, NONPARAMETRIC; THROMBOCYTOPENIA;

EID: 77952478433     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/130265     Document Type: Article

References (52)

1. Sekigawa I., Naito T., Hira K., Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy Lupus 2004 13 4 217 222
2. Love L. A., New environmental agents associated with lupus-like disorders Lupus 1994 3 6 467 471
3. Jnsen A., Bengtsson A., Nived O., Truedsson L., Sturfelt G., Gene-environment interactions in the aetiology of systemic lupus erythematosus Autoimmunity 2007 40 8 613 617
4. Crispn J. C., Tsokos G. C., Novel molecular targets in the treatment of systemic lupus erythematosus Autoimmunity Reviews 2008 7 3 256 261
5. + T cells of patients with systemic lupus erythematosus Clinical Rheumatology 2008 27 1 21 27
6. Stohl W., Metyas S., Tan S. M., B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observation Arthritis and Rheumatism 2003 48 12 3475 3486
7. Grndal G., Gunnarsson I., Rnnelid J., Rogberg S., Klareskog L., Lundberg I., Cytokine production, serum levels and disease activity in systemic lupus erythematosus Clinical and Experimental Rheumatology 2000 18 5 565 570
8. Truedsson L., Bengtsson A. A., Sturfelt G., Complement deficiencies and systemic lupus erythematosus Autoimmunity 2007 40 8 560 566
9. Wong M., Tsao B. P., Current topics in human SLE genetics Springer Seminars in Immunopathology 2006 28 2 97 107
10. Harley J. B., Kelly J. A., Kaufman K. M., Unraveling the genetics of systemic lupus erythematosus Springer Seminars in Immunopathology 2006 28 2 119 130
11. Hom G., Graham R. R., Modrek B., Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX New England Journal of Medicine 2008 358 9 900 909
12. International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley J. B., Alarcn-Riquelme M. E., Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci Nature Genetics 2008 40 2 204 210
13. Prokunina L., Alarcon-Riquelme M., The genetic basis of systemic lupus erythematosus-knowledge of today and thoughts for tomorrow Human Molecular Genetics 2004 13 1 R143 R148
14. Charo I. F., Taubman M. B., Chemokines in the pathogenesis of vascular disease Circulation Research 2004 95 9 858 866
15. Stahl R. A. K., Thaiss F., Disser M., Helmchen U., Hora K., Schlndorff D., Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephriti Kidney International 1993 44 5 1036 1047
16. Rovin B. H., Doe N., Tan L. C., Monocyte chemoattractant protein-1 levels in patients with glomerular disease American Journal of Kidney Diseases 1996 27 5 640 646
17. Saitoh A., Suzuki Y., Takeda M., Kubota K., Itoh K., Tomino Y., Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy Journal of Clinical Laboratory Analysis 1998 12 1 1 5
18. Kelley V. R., Rovin B. H., Chemokines: therapeutic targets for autoimmune and inflammatory renal disease Springer Seminars in Immunopathology 2003 24 4 411 421
19. Rovin B. H., Phan L. T., Chemotactic factors and renal inflammation American Journal of Kidney Diseases 1998 31 6 1065 1084
20. Rovin B. H., Lu L., Saxena R., A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression Biochemical and Biophysical Research Communications 1999 259 2 344 348
21. Fenoglio C., Galimberti D., Lovati C., MCP-1 in Alzheimers disease patients: A-2518G polymorphism and serum levels Neurobiology of Aging 2004 25 9 1169 1173
22. Tucci M., Barnes E. V., Sobel E. S., Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis Arthritis and Rheumatism 2004 50 6 1842 1849
23. Aguilar F., Gonzlez-Escribano M. F., Snchez-Romn J., Nez-Roldn A., MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus Tissue Antigens 2001 58 5 335 338 (Pubitemid 34095143)
24. Hwang S.-Y., Cho M.-L., Park B., Allelic frequency of the MCP-1 promoter-2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Stills disease European Journal of Immunogenetics 2002 29 5 413 416
25. Kim H. L., Lee D.-S., Yang S. H., The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE American Journal of Kidney Diseases 2002 40 6 1146 1152
26. Brown K. S., Nackos E., Morthala S., Jensen L. E., Whitehead A. S., Von Feldt J. M., Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus Journal of Rheumatology 2007 34 4 740 746
27. Liao C. H., Yao T. C., Chung H. T., See L. C., Kuo M. L., Huang J. L., Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus Journal of Rheumatology 2004 31 10 2062 2067
28. Ye D. Q., Hu Y. S., Li X. P., The correlation between monocytes chemoattractant protein-1 and the arthritis of sytemic lupus erythematosus among Chinese Archives of Dermatological Research 2005 296 8 366 371
29. Tan E. M., Cohen A. S., Fries J. F., The 1982 revised criteria for the classification of systemic lupus erythrematosus Arthritis and Rheumatism 1982 25 11 1271 1277
30. Hochberg M. C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis and Rheumatism 1997 40 9 1725
31. Bombardier C., Gladman D. D., Urowitz M. B., Caron D., Chang C. H., Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE Arthritis and Rheumatism 1992 35 6 630 640
32. International HapMap Consortium, Frazer K. A., Ballinger D. G., A second generation human haplotype map of over 3.1 million SNPs Nature 2007 449 7164 851 861
33. Szalai C., Duba J., Prohszka Z., Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype in CAD patients Atherosclerosis 2001 158 1 233 239
34. Ogimoto A., Okayama H., Nagai T., Association of monocyte chemoattractant protein 1 gene polymorphism with susceptibility to nonfamilial idiopathic dilated cardiomyopathy Journal of Cardiology 2009 54 1 66 70
35. Jemaa R., Rojbani H., Kallel A., Association between the-2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients Clinica Chimica Acta 2008 390 1-2 122 125
36. Bucova M., Lietava J., Mrazek F., The MCP-1-2518 (A/G) single nucleotide polymorphism is associated with ischemic heart disease and myocardial infarction in men in the Slovak population Bratislavsk Lekrske Listy 2009 110 7 385 389
37. Yuasa S., Maruyama T., Yamamoto Y., MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes Diabetes Research and Clinical Practice 2009 86 3 193 198
38. Jemaa R., Ben Ali S., Kallel A., Association between the-2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and hypertension in Tunisian patients Clinical Biochemistry 2009 42 1-2 34 37
39. Hou S., Yang P., Du L., Monocyte chemoattractant protein-1-2518 A/G single nucleotide polymorphism in Chinese Han patients with ocular Behets disease Human Immunology 2010 71 1 79 82
40. Ozyrek A. R., Grses D., Ulger Z., Levent E., Bakiler A. R., Berdeli A., Allelic frequency of the MCP-1 promoter-2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis Clinical Rheumatology 2007 26 4 546 550
41. Karrer S., Bosserhoff A. K., Weiderer P., The-2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis Journal of Investigative Dermatology 2005 124 1 92 98
42. Gonzlez-Escribano M. F., Torres B., Aguilar F., MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis Human Immunology 2003 64 7 741 744
43. Wang L., Yang L., Gao L., Gao T. W., Li W., Liu Y. F., A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis International Journal of Immunogenetics 2008 35 1 45 49
44. Snchez E., Sabio J. M., Callejas J. L., Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus BMC Medical Genetics 2006 7, article 48
45. Lima G., Soto-Vega E., Atisha-Fregoso Y., MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus Human Immunology 2007 68 12 980 985
46. Baggiolini M., Dewald B., Moser B., Interleukin-8 and related chemotactic cytokinesCXC and CC chemokines Advances in Immunology 1994 55 97 179
47. Sica A., Wang J. M., Colotta F., Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor Journal of Immunology 1990 144 8 3034 3038
48. Satriano J. A., Hora K., Shan Z., Stanley E. R., Mori T., Schlondorff D., Regulation of monocyte chemoattractant protein-1 and macrophage colony stimulating factor-1 by IFN-gamma, tumor necrosis factor-alpha, IgG aggregates, and cAMP in mouse mesangial cells Journal of Immunology 1993 150 5 1971 1978
49. Nagahama M., Nomura S., Kanazawa S., Ozaki Y., Kagawa H., Fukuhara S., Significance of chemokines and soluble CD40 ligand in patients with autoimmune thrombocytopenic purpura European Journal of Haematology 2002 69 5-6 303 308
50. Ekdahl K. N., Bengtsson A. A., Andersson J., Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation British Journal of Haematology 2004 125 1 74 78
51. Kato K., Santana-Sahagn E., Rassenti L. Z., The soluble CD40 ligand sCD154 in systemic lupus erythematosus Journal of Clinical Investigation 1999 104 7 947 955
52. Henn V., Slupsky J. R., Grfe M., CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Nature 1998 391 6667 591 594